特邀评论：125I标记的B淋巴细胞刺激因子的靶向作用 - Suppr

Suppr

超能文献

Invited commentary: targeting of 125I-labeled B lymphocyte stimulator.

作者信息

Buchsbaum Donald J, LoBuglio Albert F

机构信息

Division of Radiation Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294-6832, USA.

出版信息

J Nucl Med. 2003 Mar;44(3):434-6.

PMID:12621011

Abstract

摘要

相似文献

Invited commentary: targeting of 125I-labeled B lymphocyte stimulator.

J Nucl Med. 2003 Mar;44(3):434-6.

Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.

J Nucl Med. 2003 Mar;44(3):422-33.

Human Genome Sciences announces clearance of IND application for LymphoRad.

Expert Rev Anticancer Ther. 2002 Jun;2(3):246-7.

BAFF-R.

J Biol Regul Homeost Agents. 2002 Jul-Sep;16(3):211-3.

Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.

Biochemistry. 2005 Feb 15;44(6):1919-31. doi: 10.1021/bi048227k.

Structural basis of BLyS receptor recognition.

Nat Struct Biol. 2002 Apr;9(4):288-92. doi: 10.1038/nsb769.

Identification of proteoglycans as the APRIL-specific binding partners.

J Exp Med. 2005 May 2;201(9):1375-83. doi: 10.1084/jem.20042309. Epub 2005 Apr 25.

Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation.

Nat Struct Biol. 2003 May;10(5):342-8. doi: 10.1038/nsb925.

B lymphocyte stimulator: a new target for treating B cell malignancies.

Chin Med J (Engl). 2008 Jul 20;121(14):1319-23.

A role for BLyS in tissue inflammation?

Arthritis Rheum. 2003 Apr;48(4):882-5. doi: 10.1002/art.10853.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Invited commentary: targeting of 125I-labeled B lymphocyte stimulator.

作者信息

Buchsbaum Donald J, LoBuglio Albert F

机构信息

Division of Radiation Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294-6832, USA.

出版信息

J Nucl Med. 2003 Mar;44(3):434-6.

PMID:12621011

Abstract

摘要

相似文献

Invited commentary: targeting of 125I-labeled B lymphocyte stimulator.

J Nucl Med. 2003 Mar;44(3):434-6.

Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.

J Nucl Med. 2003 Mar;44(3):422-33.

Human Genome Sciences announces clearance of IND application for LymphoRad.

Expert Rev Anticancer Ther. 2002 Jun;2(3):246-7.

BAFF-R.

J Biol Regul Homeost Agents. 2002 Jul-Sep;16(3):211-3.

Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.

Biochemistry. 2005 Feb 15;44(6):1919-31. doi: 10.1021/bi048227k.

Structural basis of BLyS receptor recognition.

Nat Struct Biol. 2002 Apr;9(4):288-92. doi: 10.1038/nsb769.

Identification of proteoglycans as the APRIL-specific binding partners.

J Exp Med. 2005 May 2;201(9):1375-83. doi: 10.1084/jem.20042309. Epub 2005 Apr 25.

Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation.

Nat Struct Biol. 2003 May;10(5):342-8. doi: 10.1038/nsb925.

B lymphocyte stimulator: a new target for treating B cell malignancies.

Chin Med J (Engl). 2008 Jul 20;121(14):1319-23.

A role for BLyS in tissue inflammation?

Arthritis Rheum. 2003 Apr;48(4):882-5. doi: 10.1002/art.10853.